Search

Liat Mintz

from East Brunswick, NJ
Age ~58

Liat Mintz Phones & Addresses

  • 2 Kulessa Ct, E Brunswick, NJ 08816 (732) 951-8279
  • East Brunswick, NJ
  • Kendall Park, NJ

Work

Position: Professional/Technical

Education

Degree: Graduate or professional degree

Resumes

Resumes

Liat Mintz Photo 1

Owner

View page
Location:
2 Kulessa Ct, East Brunswick, NJ 08816
Industry:
Biotechnology
Work:
Dialean
Owner

Compugen Inc 1997 - 2002
Director of Bioinformatics and Genomic Research
Education:
Tel Aviv University 1992 - 1997
Doctorates, Doctor of Philosophy, Philosophy
Skills:
Lifesciences
Business Strategy
Cell Biology
Bioinformatics
Genomics
Cell Culture
In Vitro
Protein Chemistry
Medical Devices
Elisa
Biotechnology
Personalized Medicine
Oncology
Drug Discovery
Biochemistry
Pharmaceutical Industry
Software Development
Start Ups
Cancer
Molecular Biology
Research
Venture Capital
R&D
Genetics
Entrepreneurship
Clinical Development
Pcr
Science
Animal Models
Technology Transfer
Data Analysis
Immunology
Perl
Clinical Trials
Hardware Diagnostics
Microbiology
Liat Mintz Photo 2

Liat Mintz

View page

Business Records

Name / Title
Company / Classification
Phones & Addresses
Liat Mintz
Owner
Dialean, Ltd
Commercial Biotechnical Research Services
2 Kulessa Ct, East Brunswick, NJ 08816

Publications

Us Patents

Hepatocyte Growth Factor Receptor Splice Variants And Methods Of Using Same

View page
US Patent:
7678769, Mar 16, 2010
Filed:
Jul 23, 2007
Appl. No.:
11/781905
Inventors:
Galit Rotman - Herzilya, IL
Merav Beiman - Ness Ziona, IL
Michal Ayalon-Soffer - Ramat-HaSharon, IL
Zurit Levine - Herzlia, IL
Chen Hermesh - Karkur, IL
Anat Oren - Ramat-Aviv, IL
Zohar Tiran - Petach Tikva, IL
Dvir Dahary - Tel-Aviv, IL
Liat Mintz - East Brunswick NJ, US
Hanqing Xie - Lambertville NJ, US
Assignee:
Compugen, Ltd. - Tel Aviv
International Classification:
A61K 38/00
C07K 14/00
US Classification:
514 12, 514 2, 530350, 424 91, 536 231
Abstract:
Novel polypeptides that are splice variants of c-Met, the receptor for hepatocyte growth factor and polynucleotides encoding same are provided. Methods and pharmaceutical compositions which can be used to treat various disorders such as cancer, immunological-related, blood-related and skin-related disorders using the polypeptides and polynucleotides of the present invention, are also provided.

Human Thrombospondin Polypeptide

View page
US Patent:
7745391, Jun 29, 2010
Filed:
May 31, 2006
Appl. No.:
11/443428
Inventors:
Liat Mintz - East Brunswick NJ, US
Hanqing Xie - Lambertville NJ, US
Dvir Dahary - Tel-Aviv, IL
Erez Levanon - Petach-Tikva, IL
Shiri Freilich - Herzlia, IL
Nili Beck - Kfar Saba, IL
Wei-Yong Zhu - Plainsboro NJ, US
Alon Wasserman - Rehovot, IL
Jeanne Bernstein - Kfar Yona, IL
Assignee:
Compugen Ltd. - Tel-Aviv
International Classification:
A61K 38/00
C07K 14/00
US Classification:
514 2, 514 12, 530350
Abstract:
A human thrombospondin 1 protein, polynucleotide encoding the protein, and pharmaceutical composition thereof.

Use Of Ghrelin Splice Variant For Treating Cachexia And/Or Anorexia And/Or Anorexia-Cachexia And/Or Malnutrition And/Or Lipodystrophy And/Or Muscle Wasting And/Or Appetite-Stimulation

View page
US Patent:
7763707, Jul 27, 2010
Filed:
Sep 26, 2008
Appl. No.:
12/239229
Inventors:
Liat Mintz - East Brunswick NJ, US
International Classification:
C07K 14/575
A61K 38/17
A61K 38/22
US Classification:
530324, 514 2, 514 12, 514 13, 514 14, 514 15, 514 16, 530300, 530325, 530326, 530327, 530328, 530329
Abstract:
The present disclosure relates, in one aspect, to use of ghrelin splice variant or an analogue thereof for the preparation of a medicament for one or more of: treatment and/or prevention of loss of body weight and body fat, prophylaxis or treatment of cachexia, stimulation of appetite, stimulation of food intake, stimulation of weight gain, or increasing body fat mass, or increasing body lean mass. Another aspect relates to the use of a ghrelin splice variant-like compound for the preparation of a medicament for the prophylaxis or treatment of cancer cachexia in an individual in need of such treatment. Another aspect relates to the use of a ghrelin splice variant-like compound for the preparation of a medicament for prophylaxis or treatment of cachexia in an individual by administering a subcutaneous dosage of said medicament to the individual. A further aspect relates to the use of a ghrelin splice variant-like compound or a pharmaceutically acceptable salt thereof for the preparation of a medicament for stimulation of appetite in an individual by administering a subcutaneous dosage of said medicament to the individual. A further aspect relates to a number of new ghrelin splice variant-like compounds and uses thereof, as well as to pharmaceutical compositions and medical packaging comprising the new ghrelin splice variant-like compounds.

Compositions, Reagents And Kits For And Methods Of Diagnosing, Monitoring And Treating Hormonal Imbalance

View page
US Patent:
7858744, Dec 28, 2010
Filed:
Nov 1, 2006
Appl. No.:
11/591649
Inventors:
Liat Mintz - East Brunswick NJ, US
Assignee:
Dialean, Ltd.
International Classification:
C07K 14/435
C07K 14/605
US Classification:
530350, 530308
Abstract:
The present invention concerns ten novel variants of alternative splicing of the hormonal imbalance related genes.

Use Of Ghrelin Splice Variant For Treating Cachexia And/Or Anorexia And/Or Anorexia-Cachexia And/Or Malnutrition And/Or Lipodystrophy And/Or Muscle Wasting And/Or Appetite-Stimulation

View page
US Patent:
7981860, Jul 19, 2011
Filed:
Mar 9, 2007
Appl. No.:
11/716137
Inventors:
Liat Mintz - East Brunswick NJ, US
International Classification:
A61K 38/22
A61K 38/25
A61K 38/10
US Classification:
514 49, 514 53, 514 48, 530300
Abstract:
The present disclosure relates, in one aspect, to use of ghrelin splice variant or an analogue thereof for the preparation of a medicament for one or more of: treatment and/or prevention of loss of body weight and body fat, prophylaxis or treatment of cachexia, stimulation of appetite, stimulation of food intake, stimulation of weight gain, or increasing body fat mass, or increasing body lean mass. Another aspect relates to the use of a ghrelin splice variant-like compound for the preparation of a medicament for the prophylaxis or treatment of cancer cachexia in an individual in need of such treatment. Another aspect relates to the use of a ghrelin splice variant-like compound for the preparation of a medicament for prophylaxis or treatment of cachexia in an individual by administering a subcutaneous dosage of said medicament to the individual. A further aspect relates to the use of a ghrelin splice variant-like compound or a pharmaceutically acceptable salt thereof for the preparation of a medicament for stimulation of appetite in an individual by administering a subcutaneous dosage of said medicament to the individual. A further aspect relates to a number of new ghrelin splice variant-like compounds and uses thereof, as well as to pharmaceutical compositions and medical packaging comprising the new ghrelin splice variant-like compounds.

Ghrelin Variant Protein

View page
US Patent:
8088730, Jan 3, 2012
Filed:
Oct 13, 2006
Appl. No.:
11/580472
Inventors:
Liat Mintz - East Brunswick NJ, US
International Classification:
A61P 3/04
A61K 38/00
C07K 14/575
US Classification:
514 49, 514 48, 514 53, 530300, 530324, 530325, 530326, 530350
Abstract:
The present invention concerns thirteen novel variants of alternative splicing of the obesity and/or diabetes related genes.

Oligonucleotide Library For Detecting Rna Transcripts And Splice Variants That Populate A Transcriptome

View page
US Patent:
20030165843, Sep 4, 2003
Filed:
Jul 20, 2001
Appl. No.:
09/908975
Inventors:
Avi Shoshan - New York NY, US
Alon Wasserman - New York NY, US
Eli Mintz - Kendall Park NJ, US
Liat Mintz - Kendall Park NJ, US
Simchon Faigler - Edison NJ, US
International Classification:
C12Q001/68
C07H021/04
US Classification:
435/006000, 536/023100, 536/024300
Abstract:
The present invention provides oligonucleotide libraries capable of detecting RNA transcripts and RNA splice variants which populate a transcriptome and which are transcribed from genes or transcription units that populate the corresponding genome. The present invention also provides oligonucleotide arrays generated from the oligonucleotide libraries and methods of using the oligonucleotide libraries in various oligonucleotide detection systems and expression profiling studies. Antisense molecules and double-stranded interfering RNAs, which are types of oligonucleotides, based on the oligonucleotides disclosed herein also are provided.

Novel Polynucleotides Encoding Soluble Polypeptides And Methods Using Same

View page
US Patent:
20040248157, Dec 9, 2004
Filed:
Jan 27, 2004
Appl. No.:
10/764833
Inventors:
Michal Ayalon-Soffer - Ramat HaSharon, IL
Sarah Pollock - Tel Aviv, IL
Alex Diber - Herzlia, IL
Zurit Levine - Herzlia, IL
Sergey Nemzer - Ramat Gan, IL
Dvir Dahary - Tel Aviv, IL
Rotem Sorek - Rehovot, IL
Erez Levanon - Petach Tikva, IL
Galit Rotman - Herzlia, IL
Kinneret Savitsky - Tel Aviv, IL
Chen Chermesh - Mishmar HaShiva, IL
Liat Mintz - East Brunswick NJ, US
Shiri Freilich - Haifa, IL
Nili Beck - Kfar Saba, IL
Wei-Yong Zhu - Plainsboro NJ, US
Alon Wasserman - New York NY, US
Idit Azar - Tel Aviv, IL
Jeanne Bernstein - Kfar Yona, IL
International Classification:
C12Q001/68
C07H021/04
US Classification:
435/006000, 435/069100, 435/320100, 435/325000, 530/324000, 536/023500
Abstract:
An isolated polynucleotide is provided. The isolated polynucleotide comprising a nucleic acid sequence encoding a polypeptide having an amino acid sequence at least 70% identical to SEQ ID NO: 1, as determined using the LALIGN software of EMBnet Switzerland (http://www.ch.embnet.org/index.html) using default parameters
Liat Mintz from East Brunswick, NJ, age ~58 Get Report